Connect with us

Psilocybin

Minerco Launches a Unique Triple Play Investment in Psychedelic Drugs, Cannabis and Its SHRUCOIN Crypto Currency

Once known solely as the Magic Mushroom Company, Minerco, Inc. (OTC: MINE) has become a bold triple play company with their research, distribution and…

Published

on

Once known solely as the Magic Mushroom Company, Minerco, Inc. (OTC: MINE) has become a bold triple play company with their research, distribution and production of psychedelics, cannabis and cryptocurrency. With a background of its Jamaican-based vertically integrated operation producing microdose tablets and capsules of psilocybin, Minerco also recently announced the acquisition of WLCCO Inc., a Jamaican-based white label CBD company that generates approximately $2.5 million in annual revenue.  This acquisition includes crucial equipment, increasing the company’s psilocybin production capacity to one million microdose units daily. The acquisition is viewed by Minerco in helping to realize a crucial goal, preparing the company to enter new legal markets in the United States. Psychedelic Drugs and Mental Health Opportunities  The ongoing Covid-19 pandemic has brought increased focus to the importance of mental health and has sparked innovation from companies working to provide treatments for mental health issues such as anxiety, depression and post-traumatic stress disorder (PTSD).  Psychedelic drugs have been at the forefront of innovation in this space, as evidence ... Full story available on Benzinga.com

Read More

Trending